Artificial intelligence (AI) has seen significant investment in drug development, but success comes down to the quality of inputs and use of AI models, according to Niven R. Narain, CEO of BPGbio. GEN has compiled a list of 10 leading AI-based drug discovery and development companies, including Anima Biotech, Atomwise, BPGbio, Generate Biomedicines, Insilico Medicine, Model Medicines, Nimbus Therapeutics, Recursion Pharmaceuticals, Relay Therapeutics and Schrödinger.
Ransomware Gangs Seek Pen Testers to Boost Quality
Ransomware groups and cybercriminal organisations are hiring cybersecurity professionals to create ransomware and improve their existing attack tools, according to a report by Cato Networks.
